DXY, EUR/USD, USD/JPY, GBP/USD, AUD/USD, USD/CAD
HELIOS AND MATHESON ANALYTICS INC - COMMON STOCK, PROTEOSTASIS THERAPEUTICS, INC. - COMMON STOCK, CARDIFF LEXINGTON CORPORATION, ENDOCYTE, INC. - COMMON STOCK, ADVANCED MICRO DEVICES, INC. - COMMON STOCK, ISHARES MSCI EMERGING INDEX FUND
S&P 500, Nasdaq Composite, Dow 30, Nikkei 225, DAX Index, FTSE 100
Gold, Silver, Crude Oil, Natural Gas, Corn, Bitcoin
BTC/USD, ETH/USD, BCH/USD, XRP/USD, LTC/USD, ETC/USD
US 10Y, Euro Bund, Germany 10Y, Japan 10Y Yield, UK 10Y, India 10Y
Gold, Brent Oil, Crude Oil, CFDs on Natural Gas, Palladium, Silver
VERY RED SITUATION...ONLY SHORT...
OREX end of the year repeat with a boost off of 1.70
Price is recovering from a fall and is approaching a level in which it was found lateral
NEW START ...TARGET 42$
I saw their commercial on tv on Bloomberg last night advertising their weight loss drug contrave. Studies say that tv commercials are good for business.Here is the study summary.
only thing missing is volume. Need a big day with lots of volume to sustain the move
good to see volume coming into this. Very speculative high reward
Time to FLY 'OREX'
Put it on your watch list and watch the moves.this week
OREX expected to open at 7.85 for a Retest Gap. To learn to trade this strategy for free go to www.RealLifeTrading.com
OREX is bio-med stock under $10 poised for good growth in the future. The company is doing good things internally, and is on the brink of breaking out. I've been keeping a watch on the volume of OREX recently, along with the Stoch. and RSI. I'd give OREX another 9-11 trading days until you see long above resistance with enough volume to climb. But, the setup is ...